Focus: EBR Systems is a public biotechnology company headquartered in Sunnyvale, CA, focused on wireless cardiac stimulation devices for heart failure and cardiac resynchronization therapy. The company operates as a specialized medical device innovator in the cardiovascular space.
Profile data last refreshed 14h ago · AI intelligence enriched 3d ago
Stable — net +2 jobs in 30d
4 added, 2 removed. Backfill posture.
High-risk opportunity for risk-tolerant professionals seeking early-stage device innovation, but cash trajectory and minimal hiring signal imminent restructuring or capital event.
Help build intelligence for EBR Systems
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from EBR Systems's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Clarity Pharmaceuticals (ASX:CU6) Doses First Patient in SECuRE Prostate Cancer Therapy Trial With Copper-67 SAR-Bispecific - Kalkine
Clarity Pharmaceuticals (ASX:CU6) Doses First Patient in SECuRE Prostate Cancer Therapy Trial With Copper-67 SAR-Bispecific Kalkine
Why Are Recce Pharmaceuticals (ASX:RCE) Shares Up 9% Today? - Kalkine
Why Are Recce Pharmaceuticals (ASX:RCE) Shares Up 9% Today? Kalkine
Healthcare Pipeline Stocks Gain Ground: EBR Systems (ASX:EBR), Recce (ASX:RCE) and Ceretas (ASX:CTS) - Kalkine
Healthcare Pipeline Stocks Gain Ground: EBR Systems (ASX:EBR), Recce (ASX:RCE) and Ceretas (ASX:CTS) Kalkine
Clarity Pharmaceuticals (ASX:CU6) Completes Enrolment in Phase III CLARIFY Trial - Kalkine
Clarity Pharmaceuticals (ASX:CU6) Completes Enrolment in Phase III CLARIFY Trial Kalkine
ASX Healthcare Stocks Under Pressure: Oneview, Adheris Health and Little Green Pharma - Kalkine
ASX Healthcare Stocks Under Pressure: Oneview, Adheris Health and Little Green Pharma Kalkine
EBR Systems, Inc. (EBR.AX) Stock Price, News, Quote & History - Yahoo! Finance Canada
EBR Systems, Inc. (EBR.AX) Stock Price, News, Quote & History Yahoo! Finance Canada
Showing 6 of 10 news items
Based on last 4 crawl cycles
Recent peer-reviewed publications with author affiliations at this company
Showing 5 of 6 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo